{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:20:41Z","timestamp":1793996441939,"version":"4.8.0"},"reference-count":299,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is the third leading cause of tumor-related mortality worldwide. In recent years, the emergency of immune checkpoint inhibitor (ICI) has revolutionized the management of HCC. Especially, the combination of atezolizumab (anti-PD1) and bevacizumab (anti-VEGF) has been approved by the FDA as the first-line treatment for advanced HCC. Despite great breakthrough in systemic therapy, HCC continues to portend a poor prognosis owing to drug resistance and frequent recurrence. The tumor microenvironment (TME) of HCC is a complex and structured mixture characterized by abnormal angiogenesis, chronic inflammation, and dysregulated extracellular matrix (ECM) remodeling, collectively contributing to the immunosuppressive milieu that in turn prompts HCC proliferation, invasion, and metastasis. The tumor microenvironment coexists and interacts with various immune cells to maintain the development of HCC. It is widely accepted that a dysfunctional tumor-immune ecosystem can lead to the failure of immune surveillance. The immunosuppressive TME is an external cause for immune evasion in HCC consisting of 1) immunosuppressive cells; 2) co-inhibitory signals; 3) soluble cytokines and signaling cascades; 4) metabolically hostile tumor microenvironment; 5) the gut microbiota that affects the immune microenvironment. Importantly, the effectiveness of immunotherapy largely depends on the tumor immune microenvironment (TIME). Also, the gut microbiota and metabolism profoundly affect the immune microenvironment. Understanding how TME affects HCC development and progression will contribute to better preventing HCC-specific immune evasion and overcoming resistance to already developed therapies. In this review, we mainly introduce immune evasion of HCC underlying the role of immune microenvironment, describe the dynamic interaction of immune microenvironment with dysfunctional metabolism and the gut microbiome, and propose therapeutic strategies to manipulate the TME in favor of more effective immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1133308","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T23:57:55Z","timestamp":1675987075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":304,"title":["Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: Translating knowledge into practice","volume":"13","author":"Singal","year":"2015","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterological Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Easl clinical practice guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatol (Baltimore Md)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"New Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"New Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (Resorce): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet (London England)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet (London England)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased \u0391-fetoprotein concentrations (Reach-2): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Zhu","year":"2019","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Sci (New York NY)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00262-018-2131-2","article-title":"Defective hla class I antigen processing machinery in cancer","volume":"67","author":"Cai","year":"2018","journal-title":"Cancer immunology immunotherapy CII"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (Time) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00473-5","article-title":"Pd-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0374-6","article-title":"Can we harness the microbiota to enhance the efficacy of cancer immunotherapy","volume":"20","author":"Finlay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Sci (New York NY)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-020-1144-6","article-title":"Predictive biomarkers and mechanisms underlying resistance to Pd1\/Pd-L1 blockade cancer immunotherapy","volume":"19","author":"Ren","year":"2020","journal-title":"Mol Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal transduction targeted Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: The cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes: At the core of cancer immunotherapy","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002181","article-title":"Neoantigens in precision cancer immunotherapy: From identification to clinical applications","volume":"135","author":"Zhang","year":"2022","journal-title":"Chin Med J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-07-4912","article-title":"Isopentenyl pyrophosphate-activated Cd56+ {Gamma}{Delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma","volume":"14","author":"Alexander","year":"2008","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"Nk cells stimulate recruitment of Cdc1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cell.2016.07.046","article-title":"\u0393\u03b4 T cells support pancreatic oncogenesis by restraining \u0391\u0392 T cell activation","volume":"166","author":"Daley","year":"2016","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.642958","article-title":"Tumor-intrinsic mechanisms regulating immune exclusion in liver cancers","volume":"12","author":"Lindblad","year":"2021","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning cold into hot: Firing up the tumor microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T Cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568059","article-title":"The resistance mechanisms of lung cancer immunotherapy","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-13-0986","article-title":"Hla and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis c virus-related hepatocellular carcinoma","volume":"19","author":"Cariani","year":"2013","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26731","article-title":"Immunodominance and functional alterations of tumor-associated antigen-specific Cd8+ T-cell responses in hepatocellular carcinoma","volume":"59","author":"Flecken","year":"2014","journal-title":"Hepatol (Baltimore Md)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1154249","DOI":"10.1080\/2162402x.2016.1154249","article-title":"Natural killer cells phenotypic characterization as an outcome predictor of hcv-linked hcc after curative treatments","volume":"5","author":"Cariani","year":"2016","journal-title":"Oncoimmunology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/15384047.2018.1450116","article-title":"Tumor-infiltrating treg, mdsc, and ido expression associated with outcomes of neoadjuvant chemotherapy of breast cancer","volume":"19","author":"Li","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2170-8","article-title":"How to measure the immunosuppressive activity of mdsc: Assays, problems and potential solutions","volume":"68","author":"Bruger","year":"2019","journal-title":"Cancer immunology immunotherapy CII"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.06.010","article-title":"Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma","volume":"59","author":"Kapanadze","year":"2013","journal-title":"J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314032","article-title":"Hepatoma-intrinsic ccrk inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy","volume":"67","author":"Zhou","year":"2018","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-c motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatol (Baltimore Md)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor hif-1 promotes myeloid-derived suppressor cells accumulation through Entpd2\/Cd39l1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.273","article-title":"Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e954829","DOI":"10.4161\/21624011.2014.954829","article-title":"Myeloid derived suppressor cells-an overview of combat strategies to increase immunotherapy efficacy","volume":"4","author":"Draghiciu","year":"2015","journal-title":"Oncoimmunology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-11-2939","article-title":"Molecular pathways: Tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment","volume":"18","author":"Lu","year":"2012","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1564505","DOI":"10.1080\/2162402x.2018.1564505","article-title":"Tim-3\/Galectin-9 pathway and mmdsc control primary and secondary resistances to pd-1 blockade in lung cancer patients","volume":"8","author":"Limagne","year":"2019","journal-title":"Oncoimmunology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.003","article-title":"Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression","volume":"30","author":"Eggert","year":"2016","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma Via the Nkp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatol (Baltimore Md)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.09.4565","article-title":"Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection","volume":"25","author":"Gao","year":"2007","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-12-3381","article-title":"Higher frequencies of Garp(+)Ctla-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality","volume":"73","author":"Kalathil","year":"2013","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5171","article-title":"Amphiregulin activates regulatory T lymphocytes and suppresses Cd8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells","volume":"6","author":"Yuan","year":"2015","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.01.036","article-title":"Increase of Cd4+ Cd25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma","volume":"45","author":"Yang","year":"2006","journal-title":"J Hepatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700540","article-title":"Hepatocellular carcinoma cell supernatants increase expansion and function of Cd4(+)Cd25(+) regulatory T cells","volume":"87","author":"Cao","year":"2007","journal-title":"Lab investigation; J Tech Methods Pathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e24671","DOI":"10.1371\/journal.pone.0024671","article-title":"Selective recruitment of regulatory T cell through Ccr6-Ccl20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis","volume":"6","author":"Chen","year":"2011","journal-title":"PLos One"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23227","article-title":"Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing tgf-beta signal","volume":"107","author":"Wang","year":"2013","journal-title":"J Surg Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15129","article-title":"The long noncoding rna lnc-egfr stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion","volume":"8","author":"Jiang","year":"2017","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.47","article-title":"Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection","volume":"114","author":"Fu","year":"2016","journal-title":"Br J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with Cd8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1159\/000342801","article-title":"Tumor-infiltrating Foxp3+ tregs and Cd8+ T cells affect the prognosis of hepatocellular carcinoma patients","volume":"86","author":"Huang","year":"2012","journal-title":"Digestion"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: Mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1394138","article-title":"Immune control in hepatocellular carcinoma development and progression: Role of stromal cells","volume":"34","author":"Sprinzl","year":"2014","journal-title":"Semin liver Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.029","article-title":"Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma","volume":"62","author":"Yeung","year":"2015","journal-title":"J Hepatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: From mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1053\/j.gastro.2015.05.058","article-title":"Interleukin-8 induces expression of Foxc1 to promote transactivation of Cxcr1 and Ccl2 in hepatocellular carcinoma cell lines and formation of metastases in mice","volume":"149","author":"Huang","year":"2015","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1333213","article-title":"Colony-stimulating factor-1-Induced Aif1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma","volume":"6","author":"Cai","year":"2017","journal-title":"Oncoimmunology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.08.004","article-title":"Ctgf secreted by mesenchymal-like hepatocellular carcinoma cells plays a role in the polarization of macrophages in hepatocellular carcinoma progression","volume":"95","author":"Wang","year":"2017","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307671","article-title":"Tim-3 fosters hcc development by enhancing tgf-\u0392-Mediated alternative activation of macrophages","volume":"64","author":"Yan","year":"2015","journal-title":"Gut"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-Pd-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29681","article-title":"Hypoxia-inducible factor-1\u0391\/Interleukin-1\u0392 signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatol (Baltimore Md)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.6.2613","article-title":"Expression of Fas\/Fasl in Cd8+ T and Cd3+ Foxp3+ treg cells\u2013relationship with apoptosis of circulating Cd8+ T cells in hepatocellular carcinoma patients","volume":"15","author":"Guo","year":"2014","journal-title":"Asian Pacific J Cancer Prev APJCP"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110064","article-title":"Cxcl17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma","volume":"9","author":"Li","year":"2014","journal-title":"PLos One"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24556","article-title":"Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients","volume":"125","author":"Zhou","year":"2009","journal-title":"Int J Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00049","article-title":"Cd4+Cd25+Cd127(Low) regulatory T cells play predominant anti-tumor suppressive role in hepatitis b virus-associated hepatocellular carcinoma","volume":"6","author":"Sharma","year":"2015","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23291","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells","volume":"51","author":"Kuang","year":"2010","journal-title":"Hepatol (Baltimore Md)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102918","article-title":"Human Ccr4+ Ccr6+ Th17 cells suppress autologous Cd8+ T cell responses","volume":"188","author":"Zhao","year":"2012","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26694","article-title":"Human Cd14+ ctla-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-Dependent il-10 and indoleamine-2,3-Dioxygenase production in hepatocellular carcinoma","volume":"59","author":"Han","year":"2014","journal-title":"Hepatol (Baltimore Md)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-15-1408","article-title":"Pd-1hi identifies a novel regulatory b-cell population in human hepatoma that promotes disease progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discovery"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib","volume":"150","author":"Zhou","year":"2016","journal-title":"Gastroenterology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24508","article-title":"Cross-presentation of antigen by diverse subsets of murine liver cells","volume":"54","author":"Ebrahimkhani","year":"2011","journal-title":"Hepatol (Baltimore Md)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s40425-019-0749-z","article-title":"Immunotherapy in hepatocellular carcinoma: The complex interface between inflammation, fibrosis, and the immune response","volume":"7","author":"Keenan","year":"2019","journal-title":"J immunotherapy Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80433-1","article-title":"Human kupffer cells secrete il-10 in response to lipopolysaccharide (Lps) challenge","volume":"22","author":"Knolle","year":"1995","journal-title":"J Hepatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatol (Baltimore Md)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.014","article-title":"The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications","volume":"72","author":"Hou","year":"2020","journal-title":"J Hepatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i5.636","article-title":"Inhibition of allogeneic T-cell response by kupffer cells expressing indoleamine 2,3-dioxygenase","volume":"16","author":"Yan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-09-0901","article-title":"Kupffer cell suppression of Cd8+ T cells in human hepatocellular carcinoma is mediated by B7-H1\/Programmed death-1 interactions","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.033","article-title":"Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a Cd44-dependent fashion","volume":"59","author":"H\u00f6chst","year":"2013","journal-title":"J Hepatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201937","article-title":"Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid","volume":"190","author":"Dunham","year":"2013","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell Co-stimulation and Co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic pd-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"7","author":"Koyama","year":"2016","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000451016","article-title":"Immune checkpoint inhibition in hepatocellular carcinoma: Basics and ongoing clinical trials","author":"Kudo","year":"2017","journal-title":"Oncology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted Cd8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"Pd-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nri3790","article-title":"Clinical blockade of Pd1 and Lag3\u2013potential mechanisms of action","volume":"15","author":"Nguyen","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25397","article-title":"Pd-1 and pd-L1 upregulation promotes Cd8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients","volume":"128","author":"Shi","year":"2011","journal-title":"Int J Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23173","article-title":"Chronically inflamed livers up-regulate expression of inhibitory B7 family members","volume":"50","author":"Kassel","year":"2009","journal-title":"Hepatol (Baltimore Md)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of Cd8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","article-title":"Antibodies against immune checkpoint molecules restore functions of tumor-infiltrating T cells in hepatocellular carcinomas","volume":"153","author":"Zhou","year":"2017","journal-title":"Gastroenterology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/tan.12278","article-title":"Tim-3 expression on peripheral monocytes and Cd3+Cd16\/Cd56+Natural killer-like T cells in patients with chronic hepatitis b","volume":"83","author":"Rong","year":"2014","journal-title":"Tissue Antigens"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009504","article-title":"A crucial role for kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis c infection","volume":"5","author":"Mengshol","year":"2010","journal-title":"PLos One"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344392","article-title":"Enhanced suppressor function of Tim-3+ Foxp3+ regulatory T cells","volume":"44","author":"Gautron","year":"2014","journal-title":"Eur J Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000005749","article-title":"Immune checkpoint proteins pd-1 and Tim-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with hbv-related hepatocellular carcinoma","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25777","article-title":"Tim-3\/Galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis b virus-associated hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatol (Baltimore Md)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1205943","article-title":"Tumor immunotherapy directed at pd-1","volume":"366","author":"Ribas","year":"2012","journal-title":"New Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","article-title":"Pd-L1 (B7-H1) and pd-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci Trans Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.7326\/m17-2073","article-title":"Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: A systematic review","volume":"168","author":"Abdel-Wahab","year":"2018","journal-title":"Ann Internal Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-17-0950","article-title":"Characterization of the immune microenvironment in hepatocellular carcinoma","volume":"23","author":"Yarchoan","year":"2017","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01818","article-title":"The tnf paradox in cancer progression and immunotherapy","volume":"10","author":"Montfort","year":"2019","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5291.1379","article-title":"Liver failure and defective hepatocyte regeneration in interleukin-6-Deficient mice","volume":"274","author":"Cressman","year":"1996","journal-title":"Sci (New York NY)"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24281","article-title":"High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis b","volume":"124","author":"Wong","year":"2009","journal-title":"Int J Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10561","article-title":"Tgf-\u0392 induces M2-like macrophage polarization Via snail-mediated suppression of a pro-inflammatory phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7282","article-title":"A role for tgf-beta in the generation and expansion of Cd4+Cd25+ regulatory T cells from human peripheral blood","volume":"166","author":"Yamagiwa","year":"2001","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.00882.x","article-title":"Possible contribution of circulating transforming growth factor-Beta1 to immunity and prognosis in unresectable hepatocellular carcinoma","volume":"24","author":"Okumoto","year":"2004","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.9.5215","article-title":"Tgf-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory Cd8 T cells","volume":"174","author":"Ahmadzadeh","year":"2005","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12885-019-5670-9","article-title":"Induction of tolerogenic dendritic cells by activated tgf-\u0392\/Akt\/Smad2 signaling in rig-I-Deficient stemness-high human liver cancer cells","volume":"19","author":"Zhong","year":"2019","journal-title":"BMC Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"26r","DOI":"10.1203\/PDR.0b013e31819e76c7","article-title":"The T(Reg)\/Th17 cell balance: A new paradigm for autoimmunity","volume":"65","author":"Eisenstein","year":"2009","journal-title":"Pediatr Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-1954","article-title":"High serum transforming growth factor-\u03921 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib","volume":"21","author":"Lin","year":"2015","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32339","article-title":"Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma","volume":"125","author":"Feun","year":"2019","journal-title":"Cancer"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1172\/jci65180","article-title":"Interferon-dependent il-10 production by tregs limits tumor Th17 inflammation","volume":"123","author":"Stewart","year":"2013","journal-title":"J Clin Invest"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.015","article-title":"The functional impairment of hcc-infiltrating \u0393\u03b4 T cells, partially mediated by regulatory T cells in a tgf\u0392- and il-10-Dependent manner","volume":"58","author":"Yi","year":"2013","journal-title":"J Hepatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082173","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through pd-L1","volume":"206","author":"Kuang","year":"2009","journal-title":"J Exp Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.03.177","article-title":"Tumor-infiltrating lymphocyte activity is enhanced in tumors with low il-10 production in hbv-induced hepatocellular carcinoma","volume":"461","author":"Shi","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1447-1","article-title":"Increase in Cd14+Hla-Dr -\/Low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis","volume":"62","author":"Arihara","year":"2013","journal-title":"Cancer immunology immunotherapy CII"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200004000-00015","article-title":"Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma","volume":"231","author":"Chau","year":"2000","journal-title":"Ann Surg"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.021","article-title":"Vegf in signaling and disease: Beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e85974","DOI":"10.1172\/jci.insight.85974","article-title":"Tgf-\u0392 and vegf cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies","volume":"1","author":"Courau","year":"2016","journal-title":"JCI Insight"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-08-0742","article-title":"Focal gains of vegfa and molecular classification of hepatocellular carcinoma","volume":"68","author":"Chiang","year":"2008","journal-title":"Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-19-0074","article-title":"\u0392-catenin activation promotes immune escape and resistance to anti-Pd-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discovery"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.017","article-title":"Expression of Nkg2d ligands is downregulated by \u0392-catenin signalling and associates with hcc aggressiveness","volume":"74","author":"Cadoux","year":"2021","journal-title":"J Hepatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0321-2","article-title":"Translation control of the immune checkpoint in cancer and its therapeutic targeting","volume":"25","author":"Xu","year":"2019","journal-title":"Nat Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/s2468-1253(18)30007-4","article-title":"Defective T-cell immunity in hepatitis b virus infection: Why therapeutic vaccination needs a helping hand","volume":"3","author":"Maini","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3RI0516-222R","article-title":"Microbiota-myeloid cell crosstalk beyond the gut","volume":"100","author":"Gorjifard","year":"2016","journal-title":"J leukocyte Biol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/imr.12584","article-title":"Correlation, consequence, and functionality in microbiome-immune interplay","volume":"279","author":"Pabst","year":"2017","journal-title":"Immunol Rev"},{"key":"B134","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","article-title":"Exploring the emerging role of the microbiome in cancer immunotherapy","volume":"7","author":"Fessler","year":"2019","journal-title":"J immunotherapy Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1042\/bcj20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem J"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249418","article-title":"Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota","volume":"21","author":"Di Lorenzo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15027419","article-title":"Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma","volume":"15","author":"Sun","year":"2016","journal-title":"Genet Mol Res GMR"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i23.2938","article-title":"Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression Via treg requires Tlr4 signaling","volume":"18","author":"Yang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12180","article-title":"Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis","volume":"44","author":"Eir\u00f3","year":"2014","journal-title":"Hepatol Res Off J Japan Soc Hepatol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2745-3","article-title":"Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma","volume":"58","author":"Wang","year":"2013","journal-title":"Digestive Dis Sci"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-20-0304","article-title":"Gut microbiome directs hepatocytes to recruit mdscs and promote cholangiocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discovery"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2233-x","article-title":"Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours Via a Tlr4-dependent mechanism","volume":"67","author":"Chen","year":"2018","journal-title":"Cancer immunology immunotherapy CII"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2347-5","article-title":"Lps promotes epithelial-mesenchymal transition and activation of Tlr4\/Jnk signaling","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1172\/jci39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12093","article-title":"New insights into the role of emt in tumor immune escape","volume":"11","author":"Terry","year":"2017","journal-title":"Mol Oncol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050714","article-title":"Targeting the interplay between epithelial-to-Mesenchymal-Transition and the immune system for effective immunotherapy","volume":"11","author":"Soundararajan","year":"2019","journal-title":"Cancers"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-15-0977","article-title":"Hypoxia-induced epithelial-to-Mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis","volume":"76","author":"Ye","year":"2016","journal-title":"Cancer Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2070","article-title":"Tlr4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma","volume":"8","author":"Zhou","year":"2019","journal-title":"Cancer Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.7150\/thno.54648","article-title":"Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma","volume":"11","author":"Dai","year":"2021","journal-title":"Theranostics"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.12.019","article-title":"Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma","volume":"358","author":"Liu","year":"2015","journal-title":"Cancer Lett"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2019.07.005","article-title":"Over-expression of mir-122 promotes apoptosis of hepatocellular carcinoma Via targeting Tlr4","volume":"18","author":"Wei","year":"2019","journal-title":"Ann Hepatol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15046","article-title":"Direct inhibition of the Tlr4\/Myd88 pathway by geniposide suppresses hif-1\u0391-Independent vegf expression and angiogenesis in hepatocellular carcinoma","volume":"177","author":"Zhang","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12901","article-title":"The microbiome and cytosolic innate immune receptors","volume":"297","author":"Liwinski","year":"2020","journal-title":"Immunol Rev"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.06.011","article-title":"Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats","volume":"57","author":"Zhang","year":"2012","journal-title":"J Hepatol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23845","article-title":"Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents","volume":"52","author":"Yu","year":"2010","journal-title":"Hepatol (Baltimore Md)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i10.1493","article-title":"Gut flora and bacterial translocation in chronic liver disease","volume":"12","author":"Almeida","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1056973","article-title":"A commensal symbiotic factor derived from bacteroides fragilis promotes human Cd39(+)Foxp3(+) T cells and treg function","volume":"6","author":"Telesford","year":"2015","journal-title":"Gut Microbes"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.72","article-title":"The gut microbiome and liver cancer: Mechanisms and clinical translation","volume":"14","author":"Yu","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.1.2.11685","article-title":"The bacterial virulence factor nlea's involvement in intestinal tight junction disruption during enteropathogenic e. coli infection is independent of its putative pdz binding domain","volume":"1","author":"Thanabalasuriar","year":"2010","journal-title":"Gut Microbes"},{"key":"B162","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/nu7010017","article-title":"The impact of diet and lifestyle on gut microbiota and human health","volume":"7","author":"Conlon","year":"2014","journal-title":"Nutrients"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-017-1557-x","article-title":"Layered defense: How mucus and tight junctions seal the intestinal barrier","volume":"95","author":"Capaldo","year":"2017","journal-title":"J Mol Med (Berlin Germany)"},{"key":"B164","doi-asserted-by":"publisher","first-page":"14103","DOI":"10.1038\/s41598-018-32484-1","article-title":"Diet induced changes in the microbiota and cell composition of rabbit gut associated lymphoid tissue (Galt)","volume":"8","author":"Arrazuria","year":"2018","journal-title":"Sci Rep"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to virchow","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet (London England)"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.172","article-title":"Inflammation marker and risk of pancreatic cancer: A nested case-control study within the epic cohort","volume":"106","author":"Grote","year":"2012","journal-title":"Br J Cancer"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e34400","DOI":"10.1371\/journal.pone.0034400","article-title":"Association analysis of il-17a and il-17f polymorphisms in Chinese han women with breast cancer","volume":"7","author":"Wang","year":"2012","journal-title":"PLos One"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.005801-0","article-title":"Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: A possible pathogenic mechanism of ulcerative colitis","volume":"58","author":"Ohkusa","year":"2009","journal-title":"J Med Microbiol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2012.10.014","article-title":"Signaling pathways bridging microbial-triggered inflammation and cancer","volume":"25","author":"Kipanyula","year":"2013","journal-title":"Cell signalling"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102432","article-title":"Dysbiosis disrupts gut immune homeostasis and promotes gastric diseases","volume":"20","author":"Toor","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B172","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging inflammasome signals in tumorigenesis and potential targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B173","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-0037-1608832","article-title":"Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in chronic liver disease","volume":"37","author":"Shah","year":"2017","journal-title":"Semin liver Dis"},{"key":"B174","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(19)32137-7","article-title":"Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: Its clinical significance","volume":"73","author":"Tarao","year":"1977","journal-title":"Gastroenterology"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1136\/gut.19.10.935","article-title":"Portal and systemic bacteraemia and endotoxaemia in liver disease","volume":"19","author":"Triger","year":"1978","journal-title":"Gut"},{"key":"B176","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/s0168-8278(87)80003-x","article-title":"Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess","volume":"4","author":"Bode","year":"1987","journal-title":"J Hepatol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12856","article-title":"Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity","volume":"295","author":"Sipe","year":"2020","journal-title":"Immunol Rev"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via nkt cells","volume":"360","author":"Ma","year":"2018","journal-title":"Sci (New York NY)"},{"key":"B179","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/srep08310","article-title":"Ranking the impact of human health disorders on gut metabolism: Systemic lupus erythematosus and obesity as study cases","volume":"5","author":"Rojo","year":"2015","journal-title":"Sci Rep"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of fusobacterium nucleatum to human inhibitory receptor tigit protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2019.1581531","article-title":"Fusobacterium nucleatum supresses anti-tumor immunity by activating Ceacam1","volume":"8","author":"Gur","year":"2019","journal-title":"Oncoimmunology"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000957","article-title":"Tigit in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J immunotherapy Cancer"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1553487","article-title":"The helicobacter pylori hopq outermembrane protein inhibits immune cell activities","volume":"8","author":"Gur","year":"2019","journal-title":"Oncoimmunology"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103014","article-title":"Cd47: The next checkpoint target for cancer immunotherapy","volume":"152","author":"Feng","year":"2020","journal-title":"Crit Rev oncology\/hematology"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192282","article-title":"Intratumoral accumulation of gut microbiota facilitates Cd47-based immunotherapy via sting signaling","volume":"217","author":"Shi","year":"2020","journal-title":"J Exp Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25804","article-title":"Natural killer P46high expression defines a natural killer cell subset that is potentially involved in control of hepatitis c virus replication and modulation of liver fibrosis","volume":"56","author":"Kr\u00e4mer","year":"2012","journal-title":"Hepatol (Baltimore Md)"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","author":"Tian","year":"2013","journal-title":"Hepatol (Baltimore Md)"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15028","article-title":"The influence of microenvironment on tumor immunotherapy","volume":"286","author":"Zhang","year":"2019","journal-title":"FEBS J"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.8.4670","article-title":"Glucose availability regulates ifn-gamma production and P70s6 kinase activation in Cd8+ effector T cells","volume":"174","author":"Cham","year":"2005","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838289","article-title":"Glucose deprivation inhibits multiple key gene expression events and effector functions in Cd8+ T cells","volume":"38","author":"Cham","year":"2008","journal-title":"Eur J Immunol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.192","article-title":"Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ros-mediated apoptosis","volume":"8","author":"Jian","year":"2017","journal-title":"Cell Death Dis"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.118604","article-title":"Aerobic glycolysis is a metabolic requirement to maintain the M2-like polarization of tumor-associated macrophages","volume":"1867","author":"Md-B","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B196","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1612920114","article-title":"Cox2\/Mpges1\/Pge2 pathway regulates pd-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B199","doi-asserted-by":"publisher","first-page":"eabi8602","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate supports a metabolic-epigenetic link in macrophage polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci Adv"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110451","article-title":"Notch-mediated lactate metabolism regulates mdsc development through the Hes1\/Mct2\/C-jun axis","volume":"38","author":"Zhao","year":"2022","journal-title":"Cell Rep"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678999","article-title":"Ido1 expression in ovarian cancer induces pd-1 in T cells Via aryl hydrocarbon receptor activation","volume":"12","author":"Amobi-McCloud","year":"2021","journal-title":"Front Immunol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13827","article-title":"Reinforce the antitumor activity of Cd8(+) T cells Via glutamine restriction","volume":"109","author":"Nabe","year":"2018","journal-title":"Cancer Sci"},{"key":"B204","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","article-title":"Inflammatory T cell responses rely on amino acid transporter Asct2 facilitation of glutamine uptake and Mtorc1 kinase activation","volume":"40","author":"Nakaya","year":"2014","journal-title":"Immunity"},{"key":"B205","doi-asserted-by":"publisher","first-page":"ra97","DOI":"10.1126\/scisignal.aab2610","article-title":"Glutamine-dependent \u0391-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation","volume":"8","author":"Klysz","year":"2015","journal-title":"Sci Signaling"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep"},{"key":"B207","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.134.5.3379","article-title":"Suppression of cytotoxic T lymphocyte activation by l-ornithine","volume":"134","author":"Dr\u00f6ge","year":"1985","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108677","article-title":"Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells","volume":"34","author":"Maisonneuve","year":"2021","journal-title":"Cell Rep"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","article-title":"Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma","volume":"12","author":"Hung","year":"2021","journal-title":"Nat Commun"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","journal-title":"Nature"},{"key":"B211","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/s41467-021-22967-7","article-title":"Targeting human acyl-Coa:Cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint","volume":"12","author":"Schmidt","year":"2021","journal-title":"Nat Commun"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01720","article-title":"Nad-biosynthetic and consuming enzymes as central players of metabolic regulation of innate and adaptive immune responses in cancer","volume":"10","author":"Audrito","year":"2019","journal-title":"Front Immunol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00925","article-title":"Targeting adenosine in cancer immunotherapy to enhance T-cell function","volume":"10","author":"Vigano","year":"2019","journal-title":"Front Immunol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"Ido in the tumor microenvironment: Inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2190-4","article-title":"Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma","volume":"67","author":"Brown","year":"2018","journal-title":"Cancer immunology immunotherapy CII"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00276","article-title":"Th17 cells in cancer: The ultimate identity crisis","volume":"5","author":"Bailey","year":"2014","journal-title":"Front Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.019","article-title":"Glutathione primes T cell metabolism for inflammation","volume":"46","author":"Mak","year":"2017","journal-title":"Immunity"},{"key":"B218","doi-asserted-by":"publisher","first-page":"e4989","DOI":"10.1097\/md.0000000000004989","article-title":"Overexpression of Cd39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection","volume":"95","author":"Cai","year":"2016","journal-title":"Medicine"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27694","article-title":"Ecto-5'-Nucleotidase (Cd73) is a potential target of hepatocellular carcinoma","volume":"234","author":"Shali","year":"2019","journal-title":"J Cell Physiol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2714","article-title":"Hypoxia-inducible factors enhance the effector responses of Cd8(+) T cells to persistent antigen","volume":"14","author":"Doedens","year":"2013","journal-title":"Nat Immunol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"Pd-L1 is a novel direct target of hif-1\u0391, and its blockade under hypoxia enhanced mdsc-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402552","article-title":"Cutting edge: Hypoxia-inducible factor 1 negatively regulates Th1 function","volume":"195","author":"Shehade","year":"2015","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1002\/stem.650","article-title":"Consice review: Contribution of cancer stem cells to neovascularization","volume":"29","author":"Ping","year":"2011","journal-title":"Stem Cells (Dayton Ohio)"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002202","article-title":"Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions","volume":"13","author":"Haas","year":"2015","journal-title":"PLos Biol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-17-2725","article-title":"Cox-2\/Pge2 axis regulates Hif2\u0391 activity to promote hepatocellular carcinoma hypoxic response and reduce the sensitivity of sorafenib treatment","volume":"24","author":"Dong","year":"2018","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: Esmo clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"Of3","DOI":"10.1158\/2159-8290.Cd-nb2017-138","article-title":"Nivolumab approved for liver cancer","volume":"7","year":"2017","journal-title":"Cancer Discovery"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.12.038","article-title":"New organ allocation criteria and decreased mortality on liver transplant waiting list","volume":"134","author":"Lang","year":"2008","journal-title":"Gastroenterology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-pacific region with advanced hepatocellular carcinoma: A phase iii randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (Checkmate 040): An open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet (London England)"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.4_suppl.483","article-title":"Checkmate 459: Health-related quality of life (Hrqol) in a randomized, multicenter phase iii study of nivolumab (Nivo) versus sorafenib (Sor) as first-line (1l) treatment in patients (Pts) with advanced hepatocellular carcinoma (Ahcc)","volume":"38","author":"Edeline","year":"2020","journal-title":"J Clin Oncol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (Keynote-224): A non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1200\/jco.19.01307","article-title":"Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in keynote-240: A randomized, double-blind, phase iii trial","volume":"38","author":"Finn","year":"2020","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4012","article-title":"Nivolumab (Nivo) + ipilimumab (Ipi) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (Ahcc): Results from checkmate 040","volume":"37","author":"Yau","year":"2019","journal-title":"J Clin Oncol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.12.001","article-title":"Hepatotoxicity and metabolism of trabectedin: A literature review","volume":"51","author":"Beumer","year":"2005","journal-title":"Pharmacol Res"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in Myd88-dependent il-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Sci (New York NY)"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.348763","article-title":"Estrogen represses hepatocellular carcinoma (Hcc) growth Via inhibiting alternative activation of tumor-associated macrophages (Tams)","volume":"287","author":"Yang","year":"2012","journal-title":"J Biol Chem"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1349587","article-title":"Blocking C5ar signaling promotes the anti-tumor efficacy of pd-1\/Pd-L1 blockade","volume":"6","author":"Zha","year":"2017","journal-title":"Oncoimmunology"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317257","article-title":"Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma","volume":"69","author":"Liu","year":"2020","journal-title":"Gut"},{"key":"B242","doi-asserted-by":"publisher","first-page":"e1477459","DOI":"10.1080\/2162402x.2018.1477459","article-title":"Combination of radiation and interleukin 12 eradicates Large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment","volume":"7","author":"Wu","year":"2018","journal-title":"Oncoimmunology"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6809","article-title":"Ccl9\/Ccr1 induces Myeloid\u2212Derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model","volume":"41","author":"Li","year":"2019","journal-title":"Oncol Rep"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.01.008","article-title":"Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer","volume":"351","author":"Xu","year":"2017","journal-title":"Exp Cell Res"},{"key":"B245","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1038\/s41467-018-07402-8","article-title":"An inflammatory-ccrk circuitry drives Mtorc1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma","volume":"9","author":"Sun","year":"2018","journal-title":"Nat Commun"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1038\/srep39296","article-title":"Pd-L1(+)Mdscs are increased in hcc patients and induced by soluble factor in the tumor microenvironment","volume":"6","author":"Iwata","year":"2016","journal-title":"Sci Rep"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28362","article-title":"Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity","volume":"134","author":"Chen","year":"2014","journal-title":"Int J Cancer"},{"key":"B248","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2016.07.044","article-title":"Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model","volume":"66","author":"Li","year":"2017","journal-title":"J Hepatol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2015.110","article-title":"Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of Cd8+ T-cells","volume":"94","author":"Wei","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8435","article-title":"Genetic polymorphisms of immune checkpoint proteins pd-1 and Tim-3 are associated with survival of patients with hepatitis b virus-related hepatocellular carcinoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1051297","article-title":"Gitr engagement in combination with ctla-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo","volume":"4","author":"Pedroza-Gonzalez","year":"2015","journal-title":"Oncoimmunology"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1038\/srep35056","article-title":"Regulatory T cells, especially icos(+) Foxp3(+) regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival","volume":"6","author":"Tu","year":"2016","journal-title":"Sci Rep"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-Ccr4 mab selectively depletes effector-type Foxp3+Cd4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.039","article-title":"Tumor-associated macrophages produce interleukin 6 and signal Via Stat3 to promote expansion of human hepatocellular carcinoma stem cells","volume":"147","author":"Wan","year":"2014","journal-title":"Gastroenterology"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages Via Ccl2\/Ccr2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6660","article-title":"C\u2212C chemokine receptor type 2 promotes Epithelial\u2212to\u2212Mesenchymal transition by upregulating matrix Metalloproteinase\u22122 in human liver cancer","volume":"40","author":"Li","year":"2018","journal-title":"Oncol Rep"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-16-0866","article-title":"Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma","volume":"16","author":"Ao","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-04-3232","article-title":"Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma","volume":"65","author":"Ormandy","year":"2005","journal-title":"Cancer Res"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17030320","article-title":"Cd86\u207a\/Cd206\u207a, diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis","volume":"17","author":"Dong","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B260","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","article-title":"Crosstalk between hepatic tumor cells and macrophages Via Wnt\/\u0392-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-16-0124","article-title":"Blocking the Ccl2-Ccr2 axis using Ccl2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model","volume":"16","author":"Teng","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S86621","article-title":"Clinical development of galunisertib (Ly2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway","volume":"9","author":"Herbertz","year":"2015","journal-title":"Drug design Dev Ther"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.3_suppl.lba173","article-title":"A phase 2 study of a novel transforming growth factor-beta (Tgf-\u03921) receptor I kinase inhibitor, Ly2157299 monohydrate (Ly), in patients with advanced hepatocellular carcinoma (Hcc)","volume":"32","author":"Faivre","year":"2014","journal-title":"J Clin Oncol"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.3_suppl.326","article-title":"Safety and efficacy of combination of Gt90001, an anti-activin receptor-like kinase-1 (Alk-1) antibody, and nivolumab in patients with metastatic hepatocellular carcinoma (Hcc)","volume":"39","author":"Hsu","year":"2021","journal-title":"J Clin Oncol"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","volume":"15","author":"Khan","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-1543","article-title":"The intersection between tumor angiogenesis and immune suppression","volume":"25","author":"Rahma","year":"2019","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140559","article-title":"Vegf-a modulates expression of inhibitory checkpoints on Cd8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2018.06.002","article-title":"The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer","volume":"52","author":"Missiaen","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.00808","article-title":"Phase ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma","volume":"38","author":"Finn","year":"2020","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1518189113","article-title":"Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1017\/s0007114507839602","article-title":"The application of probiotics in cancer","author":"de Moreno de LeBlanc","year":"2007","journal-title":"Br J Nutr"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/83.5.1199","article-title":"Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from southern China","volume":"83","author":"El-Nezami","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2011.09.003","article-title":"Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during Afb\u2081-induced hepatocellular carcinoma","volume":"490","author":"Kumar","year":"2011","journal-title":"Gene"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.6453","article-title":"Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer","volume":"14","author":"Fotiadis","year":"2008","journal-title":"World J Gastroenterol"},{"key":"B275","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canlet.2020.01.002","article-title":"Gut microbiota: A new piece in understanding hepatocarcinogenesis","volume":"474","author":"Zhou","year":"2020","journal-title":"Cancer Lett"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.409","article-title":"Gut microbiota-derived propionate reduces cancer cell proliferation in the liver","volume":"107","author":"Bindels","year":"2012","journal-title":"Br J Cancer"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and Tlr4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1743492","article-title":"Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota","volume":"11","author":"Singh","year":"2020","journal-title":"Gut Microbes"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European Consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the mechanisms of faecal microbiota transplantation","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.11.008","article-title":"Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice","volume":"66","author":"Ferrere","year":"2017","journal-title":"J Hepatol"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30037","article-title":"Antibiotic-associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatol (Baltimore Md)"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Sci (New York NY)"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255","article-title":"Commensal bifidobacterium promotes antitumor immunity and facilitates anti-Pd-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B285","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut microbiome affects the response to anti-Pd-1 immunotherapy in patients with hepatocellular carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J immunotherapy Cancer"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of pd-1-Based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Sci (New York NY)"},{"key":"B287","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-Pd-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Sci (New York NY)"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-Pd-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Sci (New York NY)"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30952-5","article-title":"Modulating the microbiome to improve therapeutic response in cancer","volume":"20","author":"McQuade","year":"2019","journal-title":"Lancet Oncol"},{"key":"B290","doi-asserted-by":"publisher","first-page":"e14323","DOI":"10.15252\/emmm.202114323","article-title":"Very-Low-Carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming","volume":"13","author":"Hirschberger","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101382","article-title":"Ketogenic diet in cancer therapy","volume":"10","author":"Weber","year":"2018","journal-title":"Aging"},{"key":"B292","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer Slc43a2 alters T cell methionine metabolism and histone methylation","volume":"585","author":"Bian","year":"2020","journal-title":"Nature"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130066","article-title":"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting ctla-4","volume":"210","author":"Holmgaard","year":"2013","journal-title":"J Exp Med"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-2-3","article-title":"Mechanism of tumor rejection with doublets of ctla-4, pd-1\/Pd-L1, or ido blockade involves restored il-2 production and proliferation of Cd8(+) T cells directly within the tumor microenvironment","volume":"2","author":"Spranger","year":"2014","journal-title":"J immunotherapy Cancer"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.02.029","article-title":"Caloric restriction impairs regulatory T cells within the tumor microenvironment after radiation and primes effector T cells","volume":"110","author":"Manukian","year":"2021","journal-title":"Int J Radiat oncology biology Phys"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00280-9","article-title":"Metabolic and epigenetic regulation of T-cell exhaustion","volume":"2","author":"Franco","year":"2020","journal-title":"Nat Metab"},{"key":"B299","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1038\/s41467-021-26431-4","article-title":"Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition","volume":"12","author":"Pomatto-Watson","year":"2021","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1133308\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T23:58:02Z","timestamp":1675987082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1133308\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":299,"alternative-id":["10.3389\/fimmu.2023.1133308"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1133308","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"article-number":"1133308"}}